Partner
Stephen Bloch
SPECIAL ADVISOR, Radius Special Situations Fund
- Firm
- Radius Special Situations Fund
- Title
- SPECIAL ADVISOR
- Role
- Advisor
Claim, correct or request removal
Record updated 22 September 2026
About
Steve is currently CEO of EvolveImmune Therapeutics, a leader in next generation immunooncology. He is also chairman of Allyx Therapeutics, where its lead program is in phase 1 testing in Alzheimer’s patients. Before co-founding EvolveImmune and Allyx in 2019, Steve helped start and finance leading healthcare companies as a general partner at Canaan Partners for nearly 20 years.
Background
- Education
- Steve obtained his AB from Dartmouth College, a MA in the history of science from Harvard, and his medical degree from the University of Rochester. Steve completed his residency at Massachusetts General Hospital/Harvard Medical School (radiology) and Lenox Hill Hospital/Cornell Medical School (internal medicine).Source (opens in a new tab)
Is this you? Remove my profile
Loading relationship preview